Twin Capital Management Inc Amgen Inc Transaction History

Twin Capital Management Inc

$827 Million
Q2 2024

A detailed history of Twin Capital Management Inc transactions in Amgen Inc stock. As of the latest transaction made, Twin Capital Management Inc holds 14,462 shares of AMGN stock, worth $4.62 Million. This represents 0.55% of its overall portfolio holdings.

Number of Shares

14,462

Previous 14,279 1.28%

Holding current value

$4.62 Million

Previous $4.06 Million 11.31%

% of portfolio

0.55%

Previous 0.52%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$262.75 - $319.31 $48,083 - $58,433	183 Added 1.28%	14,462 $4.52 Million
Q1 2024 May 13, 2024	SELL	$268.87 - $324.56 $138,736 - $167,472	-516 Reduced 3.49%	14,279 $4.06 Million
Q4 2023 Jan 31, 2024	BUY	$255.7 - $288.46 $2.5 Million - $2.82 Million	9,779 Added 194.96%	14,795 $4.26 Million
Q3 2023 Nov 13, 2023	SELL	$218.65 - $271.46 $5,903 - $7,329	-27 Reduced 0.54%	5,016 $1.35 Million
Q2 2023 Aug 07, 2023	BUY	$214.27 - $253.37 $335,118 - $396,270	1,564 Added 44.96%	5,043 $1.12 Million
Q1 2023 May 08, 2023	BUY	$225.79 - $275.2 $579,377 - $706,163	2,566 Added 281.05%	3,479 $841,000
Q4 2022 Jan 31, 2023	BUY	$229.03 - $291.01 $209,104 - $265,692	913 New	913 $240,000
Q2 2022 Aug 02, 2022	SELL	$230.71 - $256.74 $2.75 Million - $3.06 Million	-11,927 Closed	0 $0
Q1 2022 May 06, 2022	BUY	$219.27 - $242.57 $11,621 - $12,856	53 Added 0.45%	11,927 $2.88 Million
Q4 2021 Feb 07, 2022	SELL	$198.88 - $227.6 $747,192 - $855,093	-3,757 Reduced 24.04%	11,874 $2.67 Million
Q3 2021 Oct 29, 2021	SELL	$212.27 - $248.7 $458,290 - $536,943	-2,159 Reduced 12.14%	15,631 $3.32 Million
Q2 2021 Aug 09, 2021	SELL	$233.58 - $259.14 $755,397 - $838,058	-3,234 Reduced 15.38%	17,790 $4.34 Million
Q1 2021 May 06, 2021	SELL	$221.91 - $258.6 $663,510 - $773,214	-2,990 Reduced 12.45%	21,024 $5.23 Million
Q4 2020 Feb 11, 2021	SELL	$216.38 - $257.67 $271,989 - $323,891	-1,257 Reduced 4.97%	24,014 $5.52 Million
Q3 2020 Nov 05, 2020	SELL	$234.65 - $260.95 $132,342 - $147,175	-564 Reduced 2.18%	25,271 $6.42 Million
Q2 2020 Aug 04, 2020	SELL	$197.81 - $242.74 $3.4 Million - $4.17 Million	-17,175 Reduced 39.93%	25,835 $6.09 Million
Q1 2020 Apr 29, 2020	SELL	$182.24 - $241.7 $87,475 - $116,016	-480 Reduced 1.1%	43,010 $8.72 Million
Q4 2019 Jan 29, 2020	SELL	$189.21 - $243.2 $2.66 Million - $3.41 Million	-14,040 Reduced 24.4%	43,490 $10.5 Million
Q3 2019 Oct 28, 2019	SELL	$174.11 - $208.62 $869,679 - $1.04 Million	-4,995 Reduced 7.99%	57,530 $11.1 Million
Q2 2019 Aug 01, 2019	SELL	$166.7 - $195.41 $5.82 Million - $6.83 Million	-34,942 Reduced 35.85%	62,525 $11.5 Million
Q1 2019 May 03, 2019	BUY	$180.87 - $203.88 $28,396 - $32,009	157 Added 0.16%	97,467 $18.5 Million
Q4 2018 Feb 04, 2019	SELL	$178.4 - $208.25 $171,264 - $199,920	-960 Reduced 0.98%	97,310 $18.9 Million
Q3 2018 Nov 08, 2018	SELL	$185.29 - $208.89 $322,775 - $363,886	-1,742 Reduced 1.74%	98,270 $20.4 Million
Q2 2018 Aug 13, 2018	BUY	$166.05 - $186.51 $1.01 Million - $1.13 Million	6,062 Added 6.45%	100,012 $18.5 Million
Q1 2018 May 01, 2018	SELL	$169.43 - $198.0 $2.04 Million - $2.38 Million	-12,011 Reduced 11.34%	93,950 $16 Million
Q4 2017 Jan 29, 2018	BUY	$168.79 - $188.59 $2 Million - $2.24 Million	11,877 Added 12.62%	105,961 $18.4 Million
Q3 2017 Nov 09, 2017	BUY	$167.29 - $191.0 $2.68 Million - $3.06 Million	16,039 Added 20.55%	94,084 $17.5 Million
Q2 2017 Aug 07, 2017	BUY	N/A	78,045	78,045 $13.4 Million

Others Institutions Holding AMGN

# of Institutions

3,055

Shares Held

409M

Call Options Held

7.19M

Put Options Held

6.26M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $171B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Twin Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Twin Capital Management Inc with notifications on news.

Account

Twin Capital Management Inc Amgen Inc Transaction History